Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.
Press releases published on April 30, 2025
Nxera Pharma’s Partner Neurocrine Biosciences Initiates Phase 3 Registrational Program of NBI-1117568 as a Potential Treatment for Adults with Schizophrenia
GlobeNewswire
·
April 30, 2025
NBI-1117568 is an oral, muscarinic M4 selective receptor agonist discovered by Nxera advancing through clinical development under a multi-program collaboration with Neurocrine For more information, please read Neurocrine’s announcement (link) Tokyo, Japan …
Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States
GlobeNewswire
·
April 30, 2025
Amicus licenses exclusive U.S. rights to commercialize DMX-200 for the treatment of Focal Segmental Glomerulosclerosis (FSGS) DMX-200 is in a pivotal Phase 3 trial for FSGS, a rare and fatal kidney disease with no FDA-approved therapies Dimerix …
Nxera Pharma Appoints Top-Ranked Biopharma Investment Analyst Shinya Tsuzuki as Head of Investor Relations
GlobeNewswire
·
April 30, 2025
Tokyo, Japan and Cambridge, UK, 1 May 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces the appointment of Shinya Tsuzuki, as Head of Investor Relations. Mr. Tsuzuki will lead Nxera’s Investor Relations (IR) team in Japan …
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
GlobeNewswire
·
April 30, 2025
Cincinnati, OH, April 30, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the “Company”) announced that it received a Staff delisting letter from The Nasdaq Capital Market (“Nasdaq”) on April 24, 2025 indicating that the Company’s failure to file …
Weebit Nano and DB HiTek to demonstrate chips integrating Weebit ReRAM at PCIM 2025
GlobeNewswire
·
April 30, 2025
HOD HASHARON, Israel and SEOUL, South Korea, April 30, 2025 (GLOBE NEWSWIRE) -- Weebit Nano Limited (ASX:WBT) (Weebit), a leading developer and licensor of advanced memory technologies for the global semiconductor industry, and tier-1 semiconductor foundry …
Scuderia Ferrari and HP Fuse Technology and Design with Special Livery for Miami Grand Prix
GlobeNewswire
·
April 30, 2025
News Highlights: Scuderia Ferrari and HP collaborate to co-engineer livery wrapping technologies pushing the boundaries of design possibilities in the near future Debut of special edition livery for Miami GP to mark the first year of title partnership With …
NVIDIA Sets Conference Call for First-Quarter Financial Results
GlobeNewswire
·
April 30, 2025
Written CFO Commentary to Be Provided Ahead of Call SANTA CLARA, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- NVIDIA will host a conference call on Wednesday, May 28, at 2 p.m. PT (5 p.m. ET) to discuss its financial results for the first quarter of fiscal …
Microvast Schedules First Quarter Earnings Call
GlobeNewswire
·
April 30, 2025
STAFFORD, Texas, April 30, 2025 (GLOBE NEWSWIRE) -- Microvast Holdings, Inc. (NASDAQ: MVST), (“Microvast” or the “Company”), a global leader in advanced battery technologies, will issue a press release reporting its consolidated financial results for the …
New Study Shows Castle Biosciences’ DecisionDx®-Melanoma Test Outperforms Staging and CP-GEP in Identifying Patients at Low Risk of Sentinel Lymph Node Positivity
GlobeNewswire
·
April 30, 2025
Patients identified as low risk by DecisionDx-Melanoma had a 2.8% sentinel lymph node (SLN) positivity rate, well below the National Comprehensive Cancer Network® (NCCN) guidelines’ 5% threshold to forgo sentinel lymph node biopsy (SLNB) surgery …
Applied Digital Enters Into a $150 Million Convertible Preferred Equity Facility to Advance Development of Ellendale Multi-Building HPC Campus
GlobeNewswire
·
April 30, 2025
Draws on the Facility are at the Company’s discretion; The Company will provide an update on a lease for the Company’s Ellendale High Performance Computing data center campus (the “Ellendale HPC Campus”) in the near term DALLAS, April 30, 2025 (GLOBE …
Ansys Announces Q1 Financial Results
GlobeNewswire
·
April 30, 2025
/ Q1 2025 Results Revenue of $504.9 million GAAP diluted earnings per share of $0.59 and non-GAAP diluted earnings per share of $1.64 GAAP operating profit margin of 11.7% and non-GAAP operating profit margin of 33.5% Operating cash flows of $398.9 million …
Wellchange Holdings Company Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
GlobeNewswire
·
April 30, 2025
New York, April 30, 2025 (GLOBE NEWSWIRE) -- Wellchange Holdings Company Limited (NASDAQ: WCT) ("Wellchange Holdings Company" or the "Company") is an enterprise software solution services provider headquartered in Hong Kong with diversified expansion …
Scorpius Holdings Provides 2024 Year-End Business Update; Implements Strategic Cost Reductions and Operational Streamlining
GlobeNewswire
·
April 30, 2025
SAN ANTONIO, April 30, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (OTC: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization ("CDMO”), today provided strategic, financial, and operational updates for …
Revolution Medicines to Report Financial Results for First Quarter 2025 After Market Close on May 7, 2025
GlobeNewswire
·
April 30, 2025
REDWOOD CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it will report financial …
zSpace Announces First Quarter 2025 Earnings and Conference Call Information
GlobeNewswire
·
April 30, 2025
SAN JOSE, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- zSpace (Nasdaq: ZSPC) (“zSpace” or the “Company”), a leading provider of augmented and virtual reality (AR/VR) solutions for education, announced today that it plans to release financial results for the …
Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference
GlobeNewswire
·
April 30, 2025
FOSTER CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious …
Codexis to Report First Quarter 2025 Financial Results on May 14
GlobeNewswire
·
April 30, 2025
REDWOOD CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced that it will report its financial results for the first …
SEALSQ Announces Agenda of its 2025 Annual General Meeting of Shareholders
GlobeNewswire
·
April 30, 2025
Geneva, Switzerland, April 30, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (“SEALSQ” or “the Company”) (NASDAQ: LAES), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, is pleased to …
Vaxart to Present at the Citizens Life Sciences Conference
GlobeNewswire
·
April 30, 2025
SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced that members of the management team will present at the Citizens Life Sciences conference taking place May 7-8, 2025. Presentation Details: Date and …
Pulmonx Reports First Quarter 2025 Financial Results
GlobeNewswire
·
April 30, 2025
REDWOOD CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the first quarter of 2025 …